IBD & Intestinal Disorders
News from the FDA/CDC
FDA approves risankizumab (Skyrizi) for Crohn’s disease
Risankizumab is already approved in the United States for the treatment of adults with active psoriatic arthritis and moderate to severe plaque...
Short Clinical Reviews
Endoscopic management of duodenal and ampullary adenomas
EMR in the duodenum is tricky because of its thin muscle layer, increased motility, and significant vascular supply.
From the Journals
Do myenteric neurons replicate in small intestine?
Researchers sought to replicate a controversial 2017 study, but this time keeping an eye on possible confounding variables.
Conference Coverage
Psychological intervention looks promising in Crohn’s disease
A combination of mindfulness and cognitive-behavioral therapy showed promise for pain, fatigue, and productivity associated with Crohn’s.
Conference Coverage
Eosinophilic diseases often overlap, raising costs
Overlap was less common in eosinophilic esophagitis, but more common in eosinophilic gastritis/eosinophilic gastroenteritis.
Conference Coverage
H. pylori antibiotics briefly disrupt gut microbiome
Researchers compared antibiotic resistance following either levofloxacin quadruple therapy or bismuth quadruple therapy.
Conference Coverage
Fidaxomicin favored over vancomycin in real-world C. diff study
Researchers compared the agents for treating both initial and recurrent Clostridioides difficile infections in a Medicare population.
Conference Coverage
Vibrating pill counters constipation
Swallowed device may work by boosting natural colonic rhythms, whereas traditional treatments for constipation generally increase motility or...
Conference Coverage
Videos may not increase vaccinations in IBD
Video messaging did not increase the percentage of people with IBD who got influenza vaccinations in a randomized trial.
Conference Coverage
Adsorbent offers promise for irritable bowel syndrome diarrhea
First developed 30 years ago in Eastern Europe, PMSPH is marketed over the counter in 30 European countries under the name Enterosgel.